Choose your country to see the products for your location
Exciting news about our digitalMLPA portfolio – two new digitalMLPA™ assays will be launched soon: NXtec™ D002 Hereditary Cancer Panel 2 and NXtec™ D024 KaryoProfiler!
Effective from 1 January 2026, we will be implementing a price increase of 3.6% on average on most of our products.
We’ve recently updated the digitalMLPA General Protocol to reflect a new recommendation for read depth - read more about this change.
P242 Pancreatitis just received a major update, with the recently released D1 version featuring nine new target probes and three new mutation-specific probes, as well as three replaced target probes and eight replaced reference probes. The updated probe content facilitates enhanced detection of HP-related genetic alterations and improves assay robustness.
Terence Diane Fabella, a PhD candidate and MRC Holland researcher, will present her work on the development of digitalMLPA assays for newborn screening at three international conferences later this year.
Exciting news about our digitalMLPA portfolio – two new digitalMLPA™ assays will be launched soon: NXtec™ D002 Hereditary Cancer Panel 2 and NXtec™ D024 KaryoProfiler!
Join our mailing list to receive the latest information about our products, technologies and website.